Shalby’s step down subsidiary -- Shalby Advanced Technologies (SAT) Inc., USA, has received U.S. Food and Drug Administration (USFDA) 510(k) Premarket Notification Clearance for Duraniom, its Primary Total Knee Replacement device with TiNbN coating, on January 14, 2025. Based on the safety and effectiveness data, USFDA has determined the device is substantially equivalent to legally marketed predicate devices.
Shalby is one of the leading multi-specialty chains of hospitals in India.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8094.85 |
| Max Healthcare Inst | 1012.35 |
| Narayana Hrudayalay | 1819.75 |
| Aster DM Healthcare | 742.40 |
| Global Health | 1200.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: